Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali Samii

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Neurology|June 23, 2012
Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomesFrances M Weaver, Kenneth A Follett, Matthew Stern, et al.
Plos Genetics|August 31, 2011
Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffeeTaye H Hamza, Honglei Chen, Erin M Hill-Burns, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 2, 2012
Common variation in the LRRK2 gene is a risk factor for Parkinson's diseaseIgnacio F Mata, Harvey Checkoway, Carolyn M Hutter, et al.
Molecular Neurodegeneration|September 25, 2015
The RAB39B p.G192R mutation causes X-linked dominant Parkinson's diseaseIgnacio F Mata, Yongwoo Jang, Chun-Hyung Kim, et al.
The Lancet. Neurology|October 21, 2006
Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international studyAlexis Elbaz, Lorene M Nelson, Haydeh Payami, et al.
Annals of Neurology|May 3, 2021
Genomewide Association Studies of LRRK2 Modifiers of Parkinson's DiseaseDongbing Lai, Babak Alipanahi, Pierre Fontanillas, et al.
The New England Journal of Medicine|January 26, 2017
Genetic Drivers of Kidney Defects in the DiGeorge SyndromeEsther Lopez-Rivera, Yangfan P Liu, Miguel Verbitsky, et al.
JAMA|July 6, 2016
Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial, Samuel Frank, Claudia M Testa, et al.
JAMA Neurology|November 17, 2015
Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials, Kevin Michael Biglan, Ira Shoulson, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Neurology|June 23, 2012
Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomesFrances M Weaver, Kenneth A Follett, Matthew Stern, et al.
Plos Genetics|August 31, 2011
Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffeeTaye H Hamza, Honglei Chen, Erin M Hill-Burns, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 2, 2012
Common variation in the LRRK2 gene is a risk factor for Parkinson's diseaseIgnacio F Mata, Harvey Checkoway, Carolyn M Hutter, et al.
Molecular Neurodegeneration|September 25, 2015
The RAB39B p.G192R mutation causes X-linked dominant Parkinson's diseaseIgnacio F Mata, Yongwoo Jang, Chun-Hyung Kim, et al.
The Lancet. Neurology|October 21, 2006
Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international studyAlexis Elbaz, Lorene M Nelson, Haydeh Payami, et al.
Annals of Neurology|May 3, 2021
Genomewide Association Studies of LRRK2 Modifiers of Parkinson's DiseaseDongbing Lai, Babak Alipanahi, Pierre Fontanillas, et al.
The New England Journal of Medicine|January 26, 2017
Genetic Drivers of Kidney Defects in the DiGeorge SyndromeEsther Lopez-Rivera, Yangfan P Liu, Miguel Verbitsky, et al.
JAMA|July 6, 2016
Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial, Samuel Frank, Claudia M Testa, et al.
JAMA Neurology|November 17, 2015
Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials, Kevin Michael Biglan, Ira Shoulson, et al.
Pageof 9